CapitolRadar

COO

CapitolRadar tracks every publicly disclosed COO trade by US congress members and corporate insiders: 39 disclosed trades (27 buys, 12 sells) by 2 tracked traders, from 2019-01-24 to 2026-09-17. Updated daily from official filings.

🔥 In the news right now: COO picked up 42 news headlines in the last 48 hours. Attention is not evidence. It tells you what people are looking at, not whether they are right.

Disclosed trades39
Tracked buyers2
Last disclosed trade2026-09-17
Price$54.59

Want a ping when Congress buys COO? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free

The Cooper Companies, Inc. (COO) — Healthcare · Medical - Instruments & Supplies, market cap about $10.6B.

Cluster watch: 4 distinct tracked traders disclosed buying COO in the last 45 days: Ro Khanna, Keel Paul A (director), Rosebrough Walter M Jr (director), Kurzius Lawrence Erik (director).

CapitolRadar analysis

28 trades, but only one disclosed trader

28 tracked COO trades span January 20, 2022 through June 22, 2026: 17 buys and 11 sells. That is six more buys than sells, but the entire record comes from one distinct trader, Ro Khanna. Khanna accounts for all 17 reported buys, with the latest dated June 22, 2026. The single-trader sample is too small to treat the buy-sell balance as evidence of broad congressional sentiment toward The Cooper Companies.

COO operates in Healthcare, within Medical - Instruments & Supplies. The disclosures identify trading activity, not the trader’s rationale, portfolio size, or view of the company. Congressional transaction reports can also appear up to 45 days after a trade, so disclosure timing may lag the underlying activity.

6 trades in 2025 Q3 marked the busiest listed quarter

Six trades were recorded in 2025 Q3, split evenly between three buys and three sells. The next-largest listed quarters were 2025 Q4, with five buys and no sells, and 2022 Q2, with five trades comprising two buys and three sells. The data also show three trades in both 2023 Q4 and 2022 Q3; one buy in each of 2024 Q4 and 2026 Q2; and one sell in 2022 Q4.

The listed quarterly entries total 25 trades and 15 buys, compared with 28 trades and 17 buys in the overall record. The provided quarter breakdown therefore does not cover the full chronology. That gap, together with the single-trader sample, limits quarter-to-quarter interpretation.

6 other tickers appear in the same buyer’s activity

Six additional stocks were also bought by the COO buyer: AJG, BAC, CCL, DASH, FDX, and IBM. Because there is only one COO buyer, each overlap represents that same individual rather than a broader group of lawmakers. The facts do not establish whether those purchases occurred near the COO trades or reflected a common strategy. Any disclosed transaction amounts are reported as ranges, so dollar values derived from them are estimates rather than exact figures.

Analysis written from the tracked record on 2026-08-31; it is refreshed whenever the underlying numbers change.

Activity by quarter

QuarterDisclosed tradesBuysSells
2026 Q3550
2026 Q2110
2025 Q4550
2025 Q3743
2024 Q4110
2023 Q4321
2022 Q4101
2022 Q3312

Who is buying COO?

TraderDisclosed buysLast buyGrade
Ro Khanna232026-09-17—
Susie Lee42019-08-30—

Disclosed trades in COO

DateWhoTypeAmount30d vs SPY
2026-09-17Ro Khannabuy$1,001 - $15,000—
2026-09-16Ro Khannabuy$1,001 - $15,000—
2026-09-14Ro Khannabuy$1,001 - $15,000—
2026-09-11Ro Khannabuy$1,001 - $15,000—
2026-09-09Ro Khannabuy$1,001 - $15,000—
2026-06-22Ro Khannabuy$1,001 - $15,000—
2025-10-24Ro Khannabuy$1,001 - $15,000—
2025-10-21Ro Khannabuy$1,001 - $15,000—
2025-10-15Ro Khannabuy$1,001 - $15,000—
2025-10-10Ro Khannabuy$1,001 - $15,000—
2025-10-01Ro Khannabuy$1,001 - $15,000—
2025-09-29Ro Khannabuy$1,001 - $15,000—
2025-09-05Ro Khannasell$1,001 - $15,000—
2025-08-26Ro Khannasell$1,000 - $15,000—
2025-08-26Ro Khannasell$1,001 - $15,000—
2025-08-04Ro Khannabuy$1,001 - $15,000—
2025-08-04Ro Khannabuy$1,000 - $15,000—
2025-07-25Ro Khannabuy$1,001 - $15,000—
2024-11-15Ro Khannabuy$1,001 - $15,000—
2023-10-31Ro Khannasell$1,001 - $15,000—

CapitolRadar signal history

NEW PICK 2026-10-11

Rep. Ro Khanna disclosed a $1,001–$15,000 purchase of COO, joining three company directors who also bought shares within 45 days. The panel passed mainly because Khanna has no verified trading history showing that his purchases outperform the S&P 500, so his signal remains unproven despite the buyer cluster. A documented record of similar trades beating the market, supported by the underlying disclosure and a confirmed entry price, would have strengthened the case enough to reconsider.

NEW PICK 2026-09-15

CooperCompanies director Lawrence Erik Kurzius disclosed a roughly $539,150 stock purchase, joining two other tracked directors who recently bought COO. The panel found the buying cluster notable, but the trade fell short because Kurzius has no verified record of outperforming SPY, so his signal remains unproven. A reliable backtested history showing that his prior purchases beat SPY would have been the strongest evidence to change the verdict.

These buyers also bought

Other stocks the tracked buyers of COO disclosed buying in the last six months: ADI (1) · APP (1) · BMO (1) · CHWY (1) · CSCO (1) · DOW (1).

About The Cooper Companies, Inc.

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europ…

Frequently asked questions

Which politicians bought COO most?

Ro Khanna leads with 23 disclosed buys, followed by Susie Lee.

How current is this page?

It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.

Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.

Join CapitolRadar free

CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.